CRISPR/Cas9 in allergic and immunologic diseases.

Goodman, Michael A; Moradi Manesh, Donya; Malik, Punam; Rothenberg, Marc E

Goodman, Michael A; Moradi Manesh, Donya; Malik, Punam; Rothenberg, Marc E.

Affiliation

Goodman MA; a Division of Allergy and Immunology , Cincinnati Children's Hospital Medical Center , Cincinnati , OH , USA.
Moradi Manesh D; b Division of Experimental Hematology and Cancer Biology and Hematology , Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center , Cincinnati , OH , USA.
Malik P; b Division of Experimental Hematology and Cancer Biology and Hematology , Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center , Cincinnati , OH , USA.
Rothenberg ME; b Division of Experimental Hematology and Cancer Biology and Hematology , Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center , Cincinnati , OH , USA.

Expert Rev Clin Immunol ; 13(1): 5-9, 2017 01.

Article in En | MEDLINE | ID: mdl-27687572

Subject(s)

CRISPR-Cas Systems; Hypersensitivity/therapy; Immune System Diseases/therapy; Animals; Cytidine Deaminase; Gene Editing; Humans; Hypersensitivity/genetics; Immune System Diseases/genetics; Translational Research, Biomedical

Key words

CRISPR/Cas9; allergic disease; gene editing; gene regulation; immunologic disease

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CRISPR-Cas Systems / Hypersensitivity / Immune System Diseases Limits: Animals / Humans Language: En Journal: Expert Rev Clin Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2017 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google